For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
The New York Post
Team Biden’s Latest Welfare Expansion: Medicaid Payments for Housing, Food, even Furniture
Co-authored by Dr. Joel Zinberg and Gary Alexander The latest front in the Biden administration’s crusade to bypass the congressional appropriations process and…
National Review
The CDC’s Premature Childhood-Vaccine Decision
The Centers for Disease Control and Prevention has proven once again how tone-deaf it is. The CDC’s independent Advisory Committee on Immunization Practices (ACIP) voted…
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters…
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters…
Blog
One Year on, FDA Sodium Guidance Still Wanting
It is the one year anniversary of the Food and Drug Administration’s (FDA) Guidance for Industry setting out goals to reduce sodium content…
New York Post
California Makes it Illegal for Doctors to Disagree with Politicians
Conformity of thought is now required whether it is online, on college campuses, or, if you are in California, in a physician-patient relationship.